Tag: global population screening market

  • Population Screening Market Forecast Analysis Through 2030 With Insights On Industry Expansion

    Population Screening Market Forecast Analysis Through 2030 With Insights On Industry Expansion

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Will Be The Estimated Market Size Of The Population Screening Market By 2030?

    The size of the population screening market has demonstrated significant growth in recent years. It is projected to increase from $31.39 billion in 2025 to $33.58 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion has been driven by factors such as the proliferation of public health screening initiatives, the presence of suitable laboratory testing infrastructure, a rise in disease awareness campaigns, the development of diagnostic laboratory networks, and the implementation of early detection methods.

    The population screening market is projected to experience robust expansion over the coming years, with its size forecast to reach $44.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period is propelled by factors such as increasing investments in precision screening technologies, wider adoption of population-level health analytics, the broadening of national screening initiatives, greater integration of digital diagnostics, and an intensified emphasis on preventive healthcare models. Significant developments expected during this period encompass the expanded application of genomic screening programs, the rising uptake of AI-based risk assessment tools, the ongoing proliferation of preventive health screening, the incorporation of advanced diagnostic technologies, and improved capabilities for data interpretation.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    Which Growth Factors Are Strengthening The Population Screening Market Landscape?

    An increasing incidence of cancer is projected to stimulate the expansion of the population screening market moving forward. Cancer is defined as a condition where specific cells within the human body proliferate uncontrollably and possess the ability to disseminate to other bodily regions, posing considerable health risks. Population screening aids in the early discovery of cancer, thereby enhancing treatment outcomes and patient prognosis. For example, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, projections showed over 35 million new cancer cases by 2050, representing a 77% increase compared to the estimated 20 million cases in 2022. Thus, the growing prevalence of cancer is propelling the growth of the population screening market.

    What Key Segment Areas Are Included In The Population Screening Market Assessment?

    The population screening market covered in this report is segmented –

    1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

    2) By Gender: Male, Female

    3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

    4) By Business: Hospitals, Research Institutes, Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

    Which Trends Are Expected To Shape The Population Screening Market?

    Leading companies operating in the population health management market are concentrating on developing generative AI-powered population health management (PHM) solutions. These advancements aim to enhance predictive analytics, personalize patient care, improve clinical decision-making, and streamline healthcare delivery for superior health outcomes across various populations. Generative AI refers to a type of artificial intelligence that can create new content, data, or solutions by learning patterns from existing data. As an illustration, in February 2024, Persistent Systems Inc, an India-based company, collaborated with Microsoft Corp, a US-based company, to introduce a Generative AI-powered Population Health Management system. This solution leverages Microsoft Azure OpenAI Service and Dynamics 365 Customer Insights to analyze Electronic Health Records (EHR). This integration enables the extraction of critical patient information, including unstructured clinical notes, which constitutes up to 80% of EHR data.

    Who Are The Businesses Driving Activity In The Population Screening Market?

    Major companies operating in the population screening market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., LabPLUS

    Access The Complete Population Screening Market Report:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Which Regional Market Leads The Population Screening Market?

    North America was the largest region in the population screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Population Screening Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

    Browse Through More Reports Similar to the Global Population Screening Market 2026, By The Business Research Company

    Facility Management Services Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/facility-management-services-global-market-report

    Healthcare Facility Management Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/healthcare-facility-management-global-market-report

    Healthcare Workforce Management System Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/healthcare-workforce-management-system-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Increasing cancer screening initiatives are boosting the population screening market

    Increasing cancer screening initiatives are boosting the population screening market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Does The Market Size Of The Population Screening Market Compare Between 2026 And 2030?

    The population screening market has experienced substantial growth in recent years. This market is projected to expand from $31.39 billion in 2025 to $33.58 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion has been driven by factors such as the broadening of public health screening programs, the presence of suitable laboratory testing infrastructure, a rise in disease awareness initiatives, the development of diagnostic laboratory networks, and the implementation of early detection approaches.

    The population screening market size is anticipated to experience substantial expansion over the upcoming years, with projections indicating a rise to $44.61 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period is primarily driven by escalating investments in precision screening technologies, the increasing utilization of population-level health analytics, the expansion of national screening programs, the growing integration of digital diagnostics, and an intensified focus on preventive healthcare models. Significant trends expected during this period include the rising adoption of genomic screening programs, an increase in the use of AI-based risk assessment tools, the growing expansion of preventive health screening, the integration of advanced diagnostic technologies, and enhanced data interpretation capabilities.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    What Major Factors Are Driving The Population Screening Market Forward?

    The escalating incidence of cancer is projected to stimulate the expansion of the population screening market moving ahead. Cancer is characterized as a state where specific cells within the human body multiply uncontrollably and have the potential to spread to other bodily regions, posing considerable health hazards. Population screening aids in the prompt detection of cancer, thereby enhancing therapeutic results and patient outlooks. For example, in February 2024, the World Health Organization, an intergovernmental organization located in Switzerland, indicated that more than 35 million new cancer diagnoses are anticipated by 2050, marking a 77% surge compared to the estimated 20 million cases in 2022. Hence, the increasing prevalence of cancer is propelling the development of the population screening market.

    How Is The Population Screening Market Organized By Segment Classification?

    The population screening market covered in this report is segmented –

    1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

    2) By Gender: Male, Female

    3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

    4) By Business: Hospitals, Research Institutes, Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

    Which Trends Are Impacting The Progress Of The Population Screening Market?

    Leading companies within the population screening market are developing advanced services, such as newborn mass screening, to improve early detection and enhance infant health outcomes. Newborn mass screening is a public health initiative where infants are tested shortly after birth for various genetic, metabolic, hormonal, and functional disorders that are not evident at birth but can lead to severe health problems if left untreated. For example, in May 2024, Shimadzu Techno-Research Inc., a contract analysis company and subsidiary of Shimadzu Corporation, a Japan-based manufacturer of precision instruments, introduced a new contract service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will test for combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), conditions that currently affect a small percentage of newborns but demand immediate intervention once diagnosed.

    Who Are The Industry Participants Involved In The Population Screening Market?

    Major companies operating in the population screening market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., LabPLUS

    Get The Full Population Screening Market Report:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Which Region Is The Top Contributor To The Population Screening Market By Share?

    North America was the largest region in the population screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Population Screening Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Browse Through More Reports Similar to the Global Population Screening Market 2026, By The Business Research Company

    Facility Management Services Market Report 2026

    https://www.thebusinessresearchcompany.com/report/facility-management-services-global-market-report

    Healthcare Facility Management Market Report

    https://www.thebusinessresearchcompany.com/report/healthcare-facility-management-global-market-report

    Healthcare Workforce Management System Market Report

    https://www.thebusinessresearchcompany.com/report/healthcare-workforce-management-system-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Population Screening Market Outlook 2026–2030: Key Business Drivers and Trends

    Population Screening Market Outlook 2026–2030: Key Business Drivers and Trends

    Uncover key drivers, emerging technologies, and competitive movements shaping the population screening market from 2026–2035 with trusted insights from The Business Research Company

    What was the valuation of the Population Screening Market in 2026, and what figure is it projected to hit by 2030?

    The population screening market size has experienced robust growth in recent years. This market is projected to expand from $31.39 billion in 2025 to $33.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion can be linked to the broadening of public health screening initiatives, the presence of laboratory testing infrastructure, heightened disease awareness programs, the expansion of diagnostic laboratory networks, and the implementation of early detection strategies.

    The population screening market is projected to experience substantial expansion in the coming years. By 2030, its value is anticipated to reach $44.61 billion, exhibiting a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period stems from several factors, including heightened investments in precision screening technologies, the expanded application of population-level health analytics, the broadening of national screening initiatives, the increasing incorporation of digital diagnostics, and a heightened emphasis on preventive healthcare approaches. Key trends expected during this period encompass the greater utilization of genomic screening programs, the surging adoption of AI-driven risk assessment tools, the widening scope of preventive health screening, the seamless integration of sophisticated diagnostic technologies, and improved capabilities for data interpretation.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    Which Drivers Are Affecting Market Participation In The Population Screening Market?

    The increasing occurrence of cancer is anticipated to drive expansion within the population screening market moving ahead. Cancer is characterized by the uncontrolled proliferation of particular cells within the human body, which can metastasize to other regions, creating serious health hazards. Early detection of cancer is facilitated by population screening, leading to better treatment results and patient outlook. As an illustration, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, reported a projection of over 35 million new cancer cases by 2050. This signifies a 77% surge when contrasted with the approximate 20 million cases in 2022. Consequently, the escalating incidence of cancer is a key factor propelling the expansion of the population screening market.

    What Segment Classifications Make Up The Population Screening Market?

    The population screening market covered in this report is segmented –

    1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

    2) By Gender: Male, Female

    3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

    4) By Business: Hospitals, Research Institutes, Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

    What Trends Are Reshaping The Dynamics Of The Population Screening Market?

    Major companies operating in the population screening market are pioneering advanced services, such as newborn mass screening, to improve early detection and enhance health outcomes for infants. Newborn mass screening is a public health initiative designed to test newborns shortly after birth for a variety of genetic, metabolic, hormonal, and functional disorders that may not be evident at birth but can lead to severe health complications if left untreated. For instance, in May 2024, Shimadzu Techno-Research Inc., a contract analysis firm and a subsidiary of Japan-based precision instruments manufacturer Shimadzu Corporation, launched a new contract service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will identify combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), conditions that presently affect a small percentage of newborns but require immediate intervention upon diagnosis.

    Which Major Industry Participants Are Leading The Population Screening Market Growth?

    Major companies operating in the population screening market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., LabPLUS

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Which Region Is Expected To Experience The Fastest Growth In The Population Screening Market?

    North America was the largest region in the population screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Population Screening Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

    Browse Through More Reports Similar to the Global Population Screening Market 2026, By The Business Research Company

    Drug Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Security Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

    Blood Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Population Screening Market Outlook 2026–2030: Key Business Drivers and Trends

    Population Screening Market Outlook 2026–2030: Key Business Drivers and Trends

    Uncover key drivers, emerging technologies, and competitive movements shaping the population screening market from 2026–2035 with trusted insights from The Business Research Company

    What was the valuation of the Population Screening Market in 2026, and what figure is it projected to hit by 2030?

    The population screening market size has experienced robust growth in recent years. This market is projected to expand from $31.39 billion in 2025 to $33.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion can be linked to the broadening of public health screening initiatives, the presence of laboratory testing infrastructure, heightened disease awareness programs, the expansion of diagnostic laboratory networks, and the implementation of early detection strategies.

    The population screening market is projected to experience substantial expansion in the coming years. By 2030, its value is anticipated to reach $44.61 billion, exhibiting a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period stems from several factors, including heightened investments in precision screening technologies, the expanded application of population-level health analytics, the broadening of national screening initiatives, the increasing incorporation of digital diagnostics, and a heightened emphasis on preventive healthcare approaches. Key trends expected during this period encompass the greater utilization of genomic screening programs, the surging adoption of AI-driven risk assessment tools, the widening scope of preventive health screening, the seamless integration of sophisticated diagnostic technologies, and improved capabilities for data interpretation.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    Which Drivers Are Affecting Market Participation In The Population Screening Market?

    The increasing occurrence of cancer is anticipated to drive expansion within the population screening market moving ahead. Cancer is characterized by the uncontrolled proliferation of particular cells within the human body, which can metastasize to other regions, creating serious health hazards. Early detection of cancer is facilitated by population screening, leading to better treatment results and patient outlook. As an illustration, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, reported a projection of over 35 million new cancer cases by 2050. This signifies a 77% surge when contrasted with the approximate 20 million cases in 2022. Consequently, the escalating incidence of cancer is a key factor propelling the expansion of the population screening market.

    What Segment Classifications Make Up The Population Screening Market?

    The population screening market covered in this report is segmented –

    1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

    2) By Gender: Male, Female

    3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

    4) By Business: Hospitals, Research Institutes, Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

    What Trends Are Reshaping The Dynamics Of The Population Screening Market?

    Major companies operating in the population screening market are pioneering advanced services, such as newborn mass screening, to improve early detection and enhance health outcomes for infants. Newborn mass screening is a public health initiative designed to test newborns shortly after birth for a variety of genetic, metabolic, hormonal, and functional disorders that may not be evident at birth but can lead to severe health complications if left untreated. For instance, in May 2024, Shimadzu Techno-Research Inc., a contract analysis firm and a subsidiary of Japan-based precision instruments manufacturer Shimadzu Corporation, launched a new contract service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will identify combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), conditions that presently affect a small percentage of newborns but require immediate intervention upon diagnosis.

    Which Major Industry Participants Are Leading The Population Screening Market Growth?

    Major companies operating in the population screening market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., LabPLUS

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Which Region Is Expected To Experience The Fastest Growth In The Population Screening Market?

    North America was the largest region in the population screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Population Screening Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

    Browse Through More Reports Similar to the Global Population Screening Market 2026, By The Business Research Company

    Drug Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Security Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

    Blood Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Population Screening Market Outlook 2026–2030: Key Business Drivers and Trends

    Population Screening Market Outlook 2026–2030: Key Business Drivers and Trends

    Uncover key drivers, emerging technologies, and competitive movements shaping the population screening market from 2026–2035 with trusted insights from The Business Research Company

    What was the valuation of the Population Screening Market in 2026, and what figure is it projected to hit by 2030?

    The population screening market size has experienced robust growth in recent years. This market is projected to expand from $31.39 billion in 2025 to $33.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion can be linked to the broadening of public health screening initiatives, the presence of laboratory testing infrastructure, heightened disease awareness programs, the expansion of diagnostic laboratory networks, and the implementation of early detection strategies.

    The population screening market is projected to experience substantial expansion in the coming years. By 2030, its value is anticipated to reach $44.61 billion, exhibiting a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period stems from several factors, including heightened investments in precision screening technologies, the expanded application of population-level health analytics, the broadening of national screening initiatives, the increasing incorporation of digital diagnostics, and a heightened emphasis on preventive healthcare approaches. Key trends expected during this period encompass the greater utilization of genomic screening programs, the surging adoption of AI-driven risk assessment tools, the widening scope of preventive health screening, the seamless integration of sophisticated diagnostic technologies, and improved capabilities for data interpretation.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    Which Drivers Are Affecting Market Participation In The Population Screening Market?

    The increasing occurrence of cancer is anticipated to drive expansion within the population screening market moving ahead. Cancer is characterized by the uncontrolled proliferation of particular cells within the human body, which can metastasize to other regions, creating serious health hazards. Early detection of cancer is facilitated by population screening, leading to better treatment results and patient outlook. As an illustration, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, reported a projection of over 35 million new cancer cases by 2050. This signifies a 77% surge when contrasted with the approximate 20 million cases in 2022. Consequently, the escalating incidence of cancer is a key factor propelling the expansion of the population screening market.

    What Segment Classifications Make Up The Population Screening Market?

    The population screening market covered in this report is segmented –

    1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

    2) By Gender: Male, Female

    3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

    4) By Business: Hospitals, Research Institutes, Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

    What Trends Are Reshaping The Dynamics Of The Population Screening Market?

    Major companies operating in the population screening market are pioneering advanced services, such as newborn mass screening, to improve early detection and enhance health outcomes for infants. Newborn mass screening is a public health initiative designed to test newborns shortly after birth for a variety of genetic, metabolic, hormonal, and functional disorders that may not be evident at birth but can lead to severe health complications if left untreated. For instance, in May 2024, Shimadzu Techno-Research Inc., a contract analysis firm and a subsidiary of Japan-based precision instruments manufacturer Shimadzu Corporation, launched a new contract service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will identify combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), conditions that presently affect a small percentage of newborns but require immediate intervention upon diagnosis.

    Which Major Industry Participants Are Leading The Population Screening Market Growth?

    Major companies operating in the population screening market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., LabPLUS

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Which Region Is Expected To Experience The Fastest Growth In The Population Screening Market?

    North America was the largest region in the population screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Population Screening Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

    Browse Through More Reports Similar to the Global Population Screening Market 2026, By The Business Research Company

    Drug Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Security Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

    Blood Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Population Screening Market Forecast 2029: Size, Share, and Competitive Landscape

    Global Population Screening Market Forecast 2029: Size, Share, and Competitive Landscape

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Projected Valuation Of The Population Screening Market In The Coming Years?

    In recent times, there has been a significant expansion in the size of the population screening market. It is projected to expand from $29.31 billion in 2024 to $31.39 billion by 2025, following a compound annual growth rate (CAGR) of 7.1%. The upsurge in historical period growth is mainly due to initiatives aimed at preventing disease, government health regulations, the escalation in healthcare expenses, and heightened awareness of disease.

    The market scale of population screening is anticipated to witness substantial expansion in the future. With a compound annual growth rate (CAGR) of 7.2%, it is projected to reach $41.4 billion by 2029. Factors contributing to this growth for the projected period are the move towards bespoke medicine, an upward aging trend and the prevalence of chronic conditions, integration of artificial intelligence and data analytics, as well as widening access to screening. Key market trends during this period are projected to be medical technology advancements, genetic studies and precision screening, telehealth and remote screening services, screening panels for multiple diseases, along with health equality and accessibility.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    Which Market Dynamics Are Playing A Critical Role In The Growth Of The Population Screening Market?

    The increase in cancer incidences is anticipated to fuel the expansion of the population screening market. Cancer happens when certain cells in a person’s body grow abnormally and invade other bodily parts. Early detection of cancer through population screening can lead to more effective treatment and improved prognosis. As an example, the American Cancer Society Inc., a US-based non profit health group, released reports in January 2023 stating that the cancer-related deaths in 2022 were 608,570, with an estimated 1.9 million fresh cancer cases, an increase from 606,520 cancer deaths in the previous year, 2021. As a result, the heightened occurrence of cancer is contributing to the growth of the population screening market.

    Which Sub-Segments Are Driving Growth Within The Population Screening Market?

    The population screeningmarket covered in this report is segmented –

    1) By Product: Hardware Equipment; Testing Or Lab; Analytics Or Interpretation

    2) By Gender: Male; Female

    3) By Age: Ages Less Than 15; 15-65; Ages 65 And Above

    4) By Business: Hospitals; Research Institutes; Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices; Sample Collection Devices; Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits; Point-Of-Care Testing; Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis; Interpretation Services; Reporting Tools

    What Future-Focused Trends Are Anticipated In The Population Screening Market?

    Leading firms in the population screening market are developing progressive services such as newborn mass screening. The goal is to boost early discovery and boost the health outcomes of infants. Newborn mass screening is a public health program that tests newborns for various hidden genetic, metabolic, hormonal, and functional disorders shortly after birth. These conditions might not be immediately obvious, but they can lead to serious health complications if they are not treated quickly. For example, in May 2024, Shimadzu Techno-Research Inc., a contract analysis firm and subsidiary of Shimadzu Corporation, a Japanese precision instrument manufacturer, rolled out a new contracted service for polymerase chain reaction (PCR) testing for broadened newborn mass screening. This service will test for serious conditions like severe combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA) which affect a small population of newborns but need urgent attention after identification.

    Which Players Are Shaping The Competitive Landscape Of The Population Screening Market?

    Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    How Do Regional Dynamics Influence The Population Screening Market Performance?

    North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

    Browse Through More Reports Similar to the Global Population Screening Market 2025, By The Business Research Company

    Population Health Management Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/population-health-management-global-market-report

    Lung Cancer Diagnostic And Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

    Cellular Health Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Population Screening Market Projected to Expand at 7.2% CAGR by 2029

    Global Population Screening Market Projected to Expand at 7.2% CAGR by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Much Larger Is The Population Screening Market Expected To Become By 2029 Compared With Its 2025 Level?

    The population screening market has observed strong expansion over recent years. It is anticipated to increase from $29.31 billion in 2024 to $31.39 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.1%. The historical growth of this market can be linked to disease prevention initiatives, government health policies, increasing healthcare costs, and greater disease awareness.

    The population screening market is projected to experience robust expansion over the coming years. It is forecast to reach $41.4 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.2%. The anticipated growth during this period can be attributed to the transition towards personalized medicine, the increasing elderly population and prevalence of chronic diseases, the integration of artificial intelligence and data analytics, and the broader availability of screening. Key developments expected in the forecast period include advancements in medical technology, the expansion of genomics and precision screening, the adoption of telehealth and remote screening, the emergence of multi-disease screening panels, and a focus on health equity and accessibility.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    Which Major Market Drivers Are Shaping The Future Of The Population Screening Market?

    The increasing occurrence of cancer is projected to stimulate the expansion of the population screening market in the future. Cancer is defined as a disease where certain cells within the body grow abnormally and disseminate to various other regions of the human system. Early detection of cancer through population screening can lead to more effective treatment options and improved patient outcomes. For example, reports released by the American Cancer Society Inc., a US-based voluntary health organization, in January 2023, indicated 608,570 cancer deaths in 2022 and an estimated 1.9 million new cancer cases, contrasting with 606,520 cancer deaths recorded in 2021. Consequently, the growing incidence of cancer is propelling the development of the population screening market.

    Which Key Segments Fueling The Population Screening Market?

    The population screeningmarket covered in this report is segmented –

    1) By Product: Hardware Equipment; Testing Or Lab; Analytics Or Interpretation

    2) By Gender: Male; Female

    3) By Age: Ages Less Than 15; 15-65; Ages 65 And Above

    4) By Business: Hospitals; Research Institutes; Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices; Sample Collection Devices; Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits; Point-Of-Care Testing; Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis; Interpretation Services; Reporting Tools

    What Are The Latest Industry Trends Transforming The Population Screening Market?

    Leading companies in the population screening market are developing advanced services, such as newborn mass screening, to improve early detection and enhance health outcomes for infants. Newborn mass screening is a public health program where newborns are examined shortly after birth for various genetic, metabolic, hormonal, and functional disorders that may not be obvious at birth but can lead to severe health issues if left untreated. For instance, in May 2024, Shimadzu Techno-Research Inc., a contract analysis company and subsidiary of Shimadzu Corporation, a Japan-based manufacturer of precision instruments, introduced a new contract service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will screen for combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which, while currently impacting a small percentage of newborns, demand immediate intervention upon diagnosis.

    Which Major Industry Participants Are Leading The Population Screening Market Growth?

    Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Which Region Currently Holds The Largest Share Of The Population Screening Market?

    North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Population Screening Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

    Browse Through More Reports Similar to the Global Population Screening Market 2025, By The Business Research Company

    Population Health Management Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/population-health-management-global-market-report

    Lung Cancer Diagnostic And Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

    Cellular Health Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Population Screening Industry Insights 2025 – Market Forecast for Executives and Planners

    Population Screening Industry Insights 2025 – Market Forecast for Executives and Planners

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Population Screening Market Size Changed, over the years?

    The size of the population screening market has seen significant expansion in recent years. Expansion is projected to continue, with the value predicted to rise from $29.31 billion in 2024 to $31.46 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3%. The number of elements driving this historic period of growth includes disease prevention initiatives, government health care strategies, escalating healthcare costs, and a surge in disease awareness.

    How Much Will the Population Screening Market Be Worth in 2029?

    In the upcoming years, the market size of population screening is anticipated to witness significant growth, expanding to $41.51 billion by 2029 with a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period can be credited to the shift towards personalized medicine, an aging population, chronic diseases, adoption of AI and data analytics, and broader screening access. Key trends identified for the forecast period incorporate advancements in medical technology, swell in genomics and precision screening, telehealth and distance screening, multi-disease screening panels, and growth in health equality and accessibility.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    Which is the Largest Company in the Population Screening Market?

    Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

    What Are the Main Market Drivers in the Population Screening Industry?

    The upward trend in cancer rates is projected to bolster the expansion of the population screening market. Cancer is a disease where certain cells in the human organism proliferate improperly and infiltrate other body parts. Early detection of cancer through population screening can potentially improve treatment results and prognosis. For example, data from the American Cancer Society Inc., a volunteer health organization in the US, revealed in January 2023 that there were 608,570 cancer fatalities in 2022 and an approximated 1.9 million new cancer instances, compared to the 606,520 cancer deaths in 2021. Consequently, the escalating incidence of cancer is fuelling the development of the population screening market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

    How Is the Population Screening Market Segments Structured?

    The population screening market covered in this report is segmented –

    1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

    2) By Gender: Male, Female

    3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

    4) By Business: Hospitals, Research Institutes, Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

    What Strategic Trends Are Transforming the Population Screening Market?

    In an effort to enhance early detection and promote better infant health outcomes, large corporations functioning in the population screening industry are bringing forth improved services such as newborn mass screening. This specific type of screening is a healthcare initiative for newborns, testing them soon after birth for a myriad of disorders which may not be detectable at birth but could cause serious health issues if left unaddressed. These disorders can be genetic, metabolic, hormonal or functional. In a recent development, Shimadzu Techno-Research Inc., which is a subsidiary of Japan’s Shimadzu Corporation known for producing precision instruments, in the month of May 2024, rolled out a new service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. The new service will screen for medical conditions like combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which, although currently impact a small proportion of newborns, mandate instant treatment following diagnosis.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Which Global Regions Offer the Highest Growth in the Population Screening Market?

    North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12587

    This Report Delivers Insight On:

    1. How big is the population screening market, and how is it changing globally?

    2. Who are the major companies in the population screening market, and how are they performing?

    3. What are the key opportunities and risks in the population screening market right now?

    4. Which products or customer segments are growing the most in the population screening market?

    5. What factors are helping or slowing down the growth of the population screening market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How the Population Screening Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025

    How the Population Screening Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Major Innovations Are Driving the Accelerated Growth of the Population Screening Market?

    The escalating incidence of cancer is anticipated to fuel advancements in the population screening market. Cancer, a disease marked by abnormal cell growth that could spread across the body, can be more effectively treated and have a favorable outlook if detected early through population screening. For example, data from the American Cancer Society Inc., a US voluntary health organization, revealed in January 2023 that the cancer-related mortalities in 2022 were around 608,570, while the new cancer diagnoses were approximately 1.9 million. This represented an increase from 606,520 deaths due to cancer in 2021. Therefore, the growing incidence of cancer is a significant factor pushing the expansion of the population screening market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    #How Will the CAGR of the Population Screening Market Influence Its Overall Growth by 2034?

    The market size for population screening has experienced robust growth in the past few years. The growth rate is expected to increase from $29.31 billion in 2024 to $31.46 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period has been influenced by initiatives for disease prevention, government health strategies, escalating healthcare costs, and heightened disease awareness.

    The size of the population screening market is anticipated to experience significant expansion in the coming years. The market is projected to reach $41.51 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period can be credited to a shift towards personalized medicine, an ageing population and the prevalence of chronic diseases, the incorporation of artificial intelligence and data analytics, and the broadening of access to screening. Key trends expected during this period include progress in medical technology, developments in genomics and precision screening, the rise of telehealth and remote screening, the introduction of multi-disease screening panels, and strides towards health equality and accessibility.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12587

    What Are the Most Significant Market Trends Transforming thePopulation Screening Market?

    Leading companies in the population screening market are introducing cutting-edge services like newborn mass screening to facilitate early detection and enhance baby health outcomes. This public health initiative entails testing newborns shortly after birth for a multitude of genetic, metabolic, hormonal, and functional disorders which, while not observable at birth, may result in significant health complications if not treated promptly. For example, Shimadzu Techno-Research Inc., a subsidiary of the Japan-based precision instrument manufacturer, Shimadzu Corporation, debuted a novel contract service in May 2024. This service delivers polymerase chain reaction (PCR) tests for expanded newborn mass screening and checks for conditions including severe combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA). Even though these disorders affect a tiny percentage of newborns, they demand swift intervention post-diagnosis.

    What Are the Top Market Players Propelling the Growth of thePopulation Screening Industry?

    Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    Which Primary Segments of the Population Screening Market Are Driving Growth and Industry Transformations?

    The population screening market covered in this report is segmented –

    1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

    2) By Gender: Male, Female

    3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

    4) By Business: Hospitals, Research Institutes, Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

    Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Population Screening Market?# Market?

    North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Gobal Population Screening Maret 2025, By The Business Research Company:

    Cellular Health Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

    Drug Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Security Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Growth Opportunities and Trends in the Population Screening Market: Key Insights for 2025-2034

    Growth Opportunities and Trends in the Population Screening Market: Key Insights for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the population screening market?

    In the recent years, the market size for population screening has experienced significant growth. It is projected to rise from $29.31 billion in 2024 to $31.46 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The previous growth can be credited to various factors such as disease prevention initiatives, government health policies, escalating healthcare costs, and heightened awareness of diseases.

    What will be the population screening market size in the future?

    Expectations are high for significant expansion in the population screening market size in the coming years, with projections of growth to $41.51 billion by 2029, at a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this predicted growth during the forecast period include a shift towards personalized medicine, an increase in aging population and chronic diseases, the integration of AI and data analytics as well as the extension of screening access. The forecasting period is also set to witness key trends such as advances in medical technology, genomics, precision screening, telehealth, remote screening, multi-disease screening panels, and an increased focus on health equity and accessibility.

    Get your population screening market report here!

    https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

    What main drivers are fueling expansion in the population screening market?

    The escalating rates of cancer are predicted to stimulate the expansion of the population screening market in the future. Cancer occurs when certain cells in the human body grow out of control and spread throughout the body. Population screening methods can successfully diagnose cancer at an earlier stage when it is more curable, and the prognosis is often more favorable. For example, the American Cancer Society Inc., a US-based non-profit health organization, released data in January 2023 stating that there were 608,570 cancer-related deaths in 2022 with nearly 1.9 million new cases of cancer, as compared to the 606,520 cancer fatalities in 2021. As such, the growing incidence of cancer is acting as a catalyst to the expansion of the population screening market.

    What key areas define the segmentation of the global population screening market?

    The population screening market covered in this report is segmented –

    1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

    2) By Gender: Male, Female

    3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

    4) By Business: Hospitals, Research Institutes, Diagnostic Labs

    Subsegments:

    1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

    2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

    3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

    Who are the dominant players expanding their reach in the population screening market?

    Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

    How are evolving market trends shaping population screening Strategies?

    In an attempt to improve infant health outcomes through early detection, major corporations in the population screening market are introducing innovative services such as newborn mass screening. This public health initiative involves testing newborns for various genetic, metabolic, hormonal, and functional disorders that may not be immediately noticeable at birth but could potentially cause serious health issues if not addressed. For instance, in May 2024, a contract analysis firm known as Shimadzu Techno-Research Inc., a subsidiary of Shimadzu Corporation, a precision instrument manufacturer based in Japan, initiated a new contract service. This service enables polymerase chain reaction (PCR) testing for expanded newborn mass screening. The tests will screen for ailments such as combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which currently affect a small number of newborns but necessitate prompt treatment following diagnosis.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12587

    Which regions are emerging as leaders in the population screening market?

    North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Cellular Health Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

    Drug Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Security Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: